Ocoxin

Quick links to important sections

Ocoxin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ocoxin

Property Description
Primary Type Multi-Component Food Supplement (Oral)
Manufacturer Focus Catalysis S.L. (Spain)
Pharmacological Class Antioxidant and Botanical Phytocomplex
Target Group Adults seeking systemic support
Origin Proprietary blend utilizing enzymatic activation

Ocoxin is classified as a branded multi-component food supplement manufactured by Catalysis S.L. in Spain, typically available as an oral solution or in capsule form. Unlike conventional prescription drugs, this preparation is a nutritional aid designed to support fundamental physiological processes. The product's positioning emphasizes its use of a specific proprietary process intended to enhance the ingredients' biological activity, focusing on bioavailability and synergistic effects.

What Key Components Make Up Ocoxin?

The formula is defined by ingredients that fall into the botanical and antioxidant pharmacological classes. Its primary active feature is a high concentration of Glycyrrhizic acid derived from licorice root, which is clinically recognized for its influence on anti-inflammatory pathways. The preparation is a phytocomplex, uniquely combining these potent plant-derived substances with essential amino acids and specific trace elements like Zinc and Copper. This particular combination relates to the synergistic action of its components.

What Is the General Purpose of Taking Ocoxin?

The general purpose of taking this preparation is to offer foundational support for the body’s natural defense mechanisms and to help maintain cellular integrity against external challenges. The integrated antioxidants are included to help mitigate the effects of oxidative stress, a state of cellular imbalance. This makes the product particularly suitable for adults experiencing periods of metabolic stress who seek to maintain overall resilience and vitality as part of their daily nutritional routine.

Regulatory References

  1. NIH: National Cancer Institute

What side effects are possible with Ocoxin?

Possible Side Effects and Safety Information

As a multi-component food supplement, Ocoxin does not have a standard regulatory label with frequency data (SmPC/FDA Prescribing Information). Its official safety profile is based on the known risks of its primary active component, Glycyrrhizic acid (GZA), as assessed by government health authorities like the NIH and WHO.

Adverse reactions associated with the key component are dose-dependent and typically observed only with excessive or chronic consumption.


Officially Documented Adverse Reactions and Physiological Systems

The most commonly reported effects linked to high intake of Glycyrrhizic acid include hypertension (elevated blood pressure), hypokalemia (low blood potassium), and edema (fluid retention). These reactions primarily affect the Vascular and Metabolism and Nutrition system-organ classes.

System-Organ Class Key Adverse Reactions (Excessive Intake)
Cardiovascular Cardiac arrhythmia, Hypertension
Renal / Urinary Kidney failure
Musculoskeletal Muscle weakness, Rhabdomyolysis

Serious adverse reactions, though considered rare, may include cardiac arrest, rhabdomyolysis, and kidney failure following prolonged, high-dose exposure.


Population-Specific Safety Constraints

Official regulatory bodies explicitly state that the key component is considered unsafe during pregnancy due to potential risks. Furthermore, its use is contraindicated in individuals with pre-existing hypertension, heart failure, kidney disease, or hormone-sensitive conditions.

Safety assessments indicate that an intake of Glycyrrhizic acid up to 100 mg/day is generally recognized as unlikely to cause adverse effects in most adults, structuring the safety profile around defined exposure limitations.

Overdose and Emergency Response

Overdose and Systemic Toxicity Profile

Excessive or chronic high-dose ingestion is associated with the toxicity profile of the key component, Glycyrrhizic acid, as documented by authoritative regulatory bodies. Manifestations arise from electrolyte-driven systemic toxicity, specifically resulting in hypokalemia (low potassium) and sodium/water retention. Clinically documented signs include severe hypertension, generalized edema, and potential effects on the musculoskeletal system such as muscle weakness and tetany.

Required Emergency Actions

The documented physiological changes may lead to severe outcomes affecting the cardiovascular system, including potential cardiac arrhythmias and acute heart failure, or neurological events such as seizures or hypertensive encephalopathy. Immediate medical attention is officially required when serious manifestations, particularly cardiac arrhythmias or profound severe myopathy (muscle damage), are observed.

Management and Monitoring

Management is strictly symptomatic and supportive, as no specific antidote is known. The official regulatory approach mandates the immediate discontinuation of the source of exposure. Procedural steps described include the monitoring of vital signs, particularly for hypertension, and necessary electrolyte replacement. Furthermore, the toxicity profile of the component includes a specific caution related to its contraindication during pregnancy due to documented fetal risks.

Therapeutic Uses of Ocoxin

What Ocoxin Treats: Main Uses and Benefits

Ocoxin is a multi-component food supplement that may be part of symptomatic management for adults dealing with symptoms related to heightened physiological activity associated with chronic illness. The primary component, Glycyrrhizic acid, is relevant in therapeutic contexts involving certain distressing symptoms.

The application of this substance includes addressing symptoms related to inflammatory or irritative states and addressing conditions involving inflammatory or irritative processes, such as chronic hepatitis.

Supportive Relief in Challenging Clinical Contexts

The supplement is commonly used as an adjuvant regimen to provide supportive symptomatic assistance for patients undergoing intensive treatments, such as chemotherapy and radiotherapy. Its application is relevant in conditions marked by increased physiological stress, focusing on symptoms that interfere with daily functioning. Specifically, it may assist with the overall symptom load by addressing discomfort from mucosal inflammation and gastrointestinal irritation. This support supports the patient during difficult episodes by easing distress.

“The product is applied in clinical settings that involve acute or unstable symptom patterns where additional management of discomfort is required.”

Quick Fact: Support for Symptoms Related to Physical Discomfort The supplement contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability and general well-being when dealing with conditions that produce significant symptomatic burden.

Eligibility and Restrictions for Use

Who Can and Cannot Use Ocoxin?

Eligibility for using Ocoxin, which is marketed as a multi-component food supplement, is primarily defined by population restrictions documented in government-registered clinical trials.

Eligibility Status by Population

Status Population Group Official Restriction Basis
Prohibited Pregnant or Lactating Patients Explicitly excluded from documented trials.
Prohibited Hypersensitivity to components Excluded based on component allergy.
Established Adults (Age ge 18) Documented as eligible in adult clinical trials.
Established Pediatric Patients (Age 7-18) Documented as eligible in specific pediatric trials.

Conditional Use and Comorbidity Restrictions

Use of the product may be conditional on a patient's underlying clinical status. Patients with certain comorbidities, such as uncontrolled or decompensated chronic diseases (e.g., severe diabetes or hypertension) or specific diseases like brain metastases, are typically excluded based on documented trial criteria. Additionally, eligibility is contingent upon having liver and renal function values that fall within specific required limits.

What should I know about interactions with other medicines?

Ocoxin Interactions with other medicines and products

The following interaction information is strictly based on an analysis of official government drug regulatory documents, such as those issued by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Ocoxin is classified as a multi-component food supplement. Consequently, it is not subject to the mandatory regulatory review process required for prescription medicinal products, which includes the establishment of an official, government-approved drug-drug interaction profile.

Interaction Scope: Official Regulatory Documentation

Category Regulatory Documentation Statement
Specific interacting medicines None explicitly listed in official government regulatory interaction sections.
Mechanistic basis of interactions None documented. No pharmacokinetic (e.g., CYP enzyme) or pharmacodynamic mechanisms are formally stated in official government regulatory documents for this product.
Timing-based interaction rules None documented. No mandatory administration separation or timing requirements are listed in official government regulatory documents.
Interaction-related restrictions None documented. No formal restrictions (e.g., do-not-combine rules) are listed in official government regulatory documents.

Resulting Interaction Structure

The official regulatory profile for this food supplement does not include a section detailing formal drug-drug or pharmacokinetic interactions. This absence means there are no officially mandated constraints regarding administration timing, specific contraindicated combinations, or exposure-modifying restrictions listed in official government sources. Official regulatory sources do not currently provide specific interaction statements regarding co-administration with other medicines or products.

Mechanism of Action

Ocoxin is a complex primarily acting at the cellular level by modulating the expression of specific regulatory proteins, including p53 and the anti-apoptotic protein Bcl-2. This interaction is foundational to influencing downstream cellular fate.

A key cascade involves a reduction in the activation of the NF-kB pathway, thereby suppressing pro-inflammatory signaling. Concurrently, it modulates cell-cycle regulatory proteins, ensuring that the cell proceeds through its phases with altered fidelity and influencing cellular viability.

Collectively, these mechanisms contribute to altered cellular homeostasis by facilitating proper apoptotic signaling processes. The overall action results in functional changes at the metabolic level through the modulation of specific metabolic pathways critical for cell maintenance.

Dosage and Administration Information

Ocoxin is an oral solution classified as a multi-component food supplement. Its instructions for use are characterized by established administration patterns. This guidance defines the standardized approach to its intake.


Official Administration Patterns

Feature Administration Guideline
Route of Administration Administered exclusively by the oral route as a ready-to-use solution.
Standard Adult Dose Typically administered as 60 ml daily, corresponding to two 30 ml single-dose vials.
Frequency and Timing The total daily dose is divided and taken twice daily, often recommended to be taken with meals (e.g., after breakfast and lunch).
Course Duration Use follows a continuous pattern, often initiated one week before concurrent intensive treatment and maintained throughout the entire treatment cycle and for a specified period (e.g., three weeks) following its conclusion.
Age-Group Rules A specific regimen utilized in pediatric contexts is one 30 ml vial daily.

Procedural Structure

The established usage protocol mandates taking the solution by mouth in a divided daily dose, ensuring the administrations are consistently timed with food. This procedural structure is designed to support the continuous, sustained administration required over the specified treatment timeline.

Recent Clinical Evidence

Overview of Studies for Ocoxin

The primary research for this multi-component food supplement has focused on its application as a supportive measure for patients undergoing intensive treatments, such as chemotherapy and radiotherapy. This evidence primarily comes from randomized controlled trials (RCTs) and various prospective clinical studies. Researchers have explored how the supplement was studied in adults with advanced-stage cancers and in a small number of pediatric patients with solid tumors.

Studies explored outcomes related to patient-reported experiences, primarily focusing on Quality of Life (QoL) measures and overall tolerability of the primary treatment. Findings describe patterns observed in these studies related to QoL scores, with some trials reporting observed patterns of change in patient-reported outcomes during treatment. The evidence level is characterized as moderate, but findings are derived mostly from smaller Phase II clinical trials, and sample sizes were modest, limiting general conclusions.

Research into the supplement for other systemic issues, particularly conditions involving periods of heightened symptoms or inflammatory states, is far more limited. For these uses, the evidence landscape is largely composed of component-based research and small, non-comparative exploratory clinical studies. The evidence level is characterized as low in this area, and further robust human trials are needed.

The majority of clinical research has focused on short-term symptom changes occurring during a pre-defined period. There is limited information for long-term outcomes that may occur after treatment completion, and long-term effects are not fully established. Data for specific groups remain insufficient, especially for older adults with multiple health conditions.

Key Studies & References

  1. The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
  2. Glycyrrhizin (Glycyrrhizic Acid)—Pharmacological Applications and Associated Molecular Mechanisms (Review of Component Research)

Frequently Asked Questions (FAQ)

Common questions about Ocoxin (FAQ)

Q: Are there any known severe side effects associated with Ocoxin?

A: Safety information available on this product focuses on the known risks of its key component, Glycyrrhizic acid, particularly when associated with excessive or chronic amounts. Officially documented adverse reactions linked to high exposure to this component include elevated blood pressure (hypertension), low blood potassium (hypokalemia), and fluid retention (edema). Serious reactions are considered rare and dose-dependent.

Q: Does Ocoxin interact with common vitamins or herbal supplements?

A: Ocoxin is classified as a food supplement, which means it is not subject to the mandatory regulatory review process that establishes a formal drug-drug interaction profile for prescription medicines. Official government regulatory documents do not provide specific interaction statements regarding co-administration with other medicines, vitamins, or general herbal products. Therefore, there are no officially mandated constraints listed.

Q: Is it common for people to feel nauseous when taking Ocoxin?

A: While the official safety warnings focus on risks related to the key component, clinical studies have monitored patient tolerance during use. These trials have reported that common digestive issues, such as nausea and vomiting, may be observed when the product is used alongside concurrent intensive treatments.

Q: Does Ocoxin carry a risk of long-term side effects?

A: Research has primarily focused on short-term symptom changes observed during a defined period of use. Official documentation indicates that there is limited information available concerning outcomes that may occur after treatment completion, and the long-term effects of the product are not fully established.

Q: Is it possible for Ocoxin to cause an allergic reaction?

A: Yes, as with any multi-component product, there is a possibility of a reaction to its ingredients. Documented trial criteria explicitly exclude individuals with a known hypersensitivity (allergy) to any of the components in the product.

Q: How long does Ocoxin stay in the body after the last use?

A: Pharmacokinetic information, which details how long a substance remains in the body, is specialized and not typically documented in public-facing food supplement regulatory profiles. Available data on the main component, Glycyrrhizic acid, indicates that it is rapidly processed into an active form which is then eliminated from the body primarily through bile.

Q: Can Ocoxin be taken alongside my usual prescribed medications?

A: The official regulatory profile does not include a section detailing formal drug-drug interactions. Because it is a food supplement, official government sources do not list any formally mandated constraints or specific contraindicated combinations to be avoided when taking it with prescribed medications.

Q: Are there different forms (like capsules vs. liquid) of Ocoxin available?

A: According to the product classification provided by the manufacturer, Ocoxin is generally available in two forms. It is provided as an oral liquid solution or it can also be found in a capsule form.

Q: What should I do if I experience an unexpected reaction to Ocoxin?

A: Official regulatory documentation does not provide personal medical advice or instructions for specific reactions. If an unexpected or concerning reaction is experienced while using the product, it is generally recommended to consult with a qualified healthcare professional.

Q: Does taking Ocoxin require any special monitoring by a doctor?

A: Documented trial criteria for eligibility require patients to have liver and renal function values that fall within specific limits before use. This suggests that a healthcare professional may monitor a patient’s underlying health status and lab values while the product is being used.

Q: Is Ocoxin supposed to be taken long-term or short-term?

A: The established usage protocol defines a continuous pattern of use related to concurrent treatments. This pattern is often maintained throughout the entire treatment cycle of concurrent therapy and for a specified period following its conclusion.

Q: Are there specific food items that should be avoided when using Ocoxin?

A: The administration protocol suggests the solution is often recommended to be taken with meals. However, official regulatory documents do not list any mandatory restrictions or specific food items that must be avoided when using the product.

Q: Can Ocoxin affect blood pressure or heart function?

A: The main component, Glycyrrhizic acid, is associated with effects on the vascular and metabolic systems, particularly with high intake. Officially documented effects include a risk of elevated blood pressure (hypertension) and cardiac arrhythmia.

Q: Is Ocoxin a type of immunotherapy or something different?

A: Ocoxin is a multi-component food supplement and a botanical phytocomplex. Its mechanism is described as acting at the cellular level by modulating the expression of specific regulatory proteins and suppressing inflammatory signaling pathways, rather than functioning as a conventional immunotherapy.

Q: Are there patient experiences reported in medical literature about Ocoxin?

A: Official research evidence includes the exploration of outcomes related to patient-reported experiences. These studies focus primarily on Quality of Life (QoL) measures and the overall tolerability of the primary treatments being supported by the product.

Q: Is Ocoxin known to interact with common pain relievers?

A: The product is a food supplement and does not have a formal, government-approved drug-drug interaction profile. Official sources state there are no specific interacting medicines explicitly listed, which includes specific classes like common pain relievers.

Q: Does the manufacturing of Ocoxin follow Good Manufacturing Practices (GMP)?

A: According to statements from the manufacturer, Catalysis S.L., their laboratories are certified and strictly controlled according to European Union Good Manufacturing Practices (GMP) standards. This certification indicates that the production processes meet recognized quality mandates.

Q: Why is it important to rely on regulatory sources when researching Ocoxin?

A: Relying on regulatory and authoritative sources is important because they provide the most factual, unbiased, and verifiable information. These sources define the product's official safety constraints, documented uses, and regulatory status, which is crucial for making informed health decisions.

Q: Can Ocoxin affect the results of lab tests?

A: Documented trial criteria require patients to have liver and renal function values within specific limits to be eligible for use. This requirement indicates that a healthcare professional may need to consider the product in the context of a patient’s specific lab test results.

Q: Does Ocoxin require a prescription?

A: Ocoxin is classified as a multi-component food supplement. Unlike conventional prescription medicines, food supplements are generally not subject to the mandatory regulatory review and prescription processes required for drug authorization.

Q: What is meant by the term 'non-directive' use conditions for Ocoxin?

A: In the context of official health content, 'non-directive' means the information provided about the product's use is descriptive and factual only. This language strictly avoids any phrasing that could be interpreted as personal medical advice, instructions, or clinical recommendations to the user.

Q: Is Ocoxin recommended for healthy people looking for prevention?

A: The general purpose of the preparation is to offer foundational support and help mitigate the effects of oxidative stress. Its focus is on adults experiencing periods of metabolic stress who seek to maintain overall resilience and vitality as part of their daily nutritional routine.

Q: Are there any common user misconceptions about what Ocoxin is or does?

A: A common point of clarification is that the product is officially classified as a multi-component food supplement. This means it has a different regulatory status and set of labeling requirements compared to a conventional prescription medicine or chemotherapy drug.

Q: Does Ocoxin have potential interaction with blood thinners?

A: The official regulatory profile does not include a section detailing formal drug-drug or pharmacokinetic interactions. Official government sources state that there are no specific interacting medicines, including classes like blood thinners, explicitly listed for this food supplement.

How should Ocoxin be stored and disposed of?

Ocoxin is a multi-component food supplement and not subject to mandatory storage and disposal regulations of a prescription drug. Instructions are based on general principles and manufacturer advice.

Storage Requirements

The product must be stored in a cool and dry place, protected from direct sunlight, excessive heat, and moisture to maintain the integrity of its components. The container must remain tightly closed and stored in its original packaging.

Critically, Ocoxin must be kept out of the sight and reach of children to prevent accidental ingestion, which is a universal safety mandate for all health products.

Disposal Instructions

Unused or expired product should be disposed of according to local municipal waste regulations and should not be placed into wastewater systems, such as flushing down the toilet or pouring down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ocoxin found in:

A-Z Index: